Skip to main content
SpringerLink
Log in

Adjuvant chemotherapy with carmustine and cisplatin for patients with malignant gliomas

  • Clinical Study
  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Summary

Forty-five patients with malignant gliomas were treated after aggressive surgical resection with alternating intravenous carmustine and cisplatin both during and after radiation therapy. Thirty-three patients were considered evaluable for responses, 17 had glioblastoma multiforme (GBM),14 had anaplastic astrocytoma (AA) and 2 had anaplastic oligodendroglioma (AO). The median age of the evaluable patients was 47 years. The median time to tumor progression was 34.5 weeks, and the median survival for the entire group was 76 weeks. Early progression occurred more frequently in patients with glioblastoma than in those with AA or AO. Seventeen patients (55%) were alive at 18 months (6 GBM, 9 AA, 2 AO). Toxicity was mainly hematologic, otic and tolerable. The results suggest that further trial is warranted to assess the efficacy of alternating carmustine and cisplatin in conjunction with radiation therapy postoperatively in patients with malignant gliomas.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Aronin PA, Mahaley MS Jr., Rudnick SA, et al.: Prediction of BCNU pulmonary toxicity in patients with malignant gliomas. N Engl J Med 303: 183–188, 1980

    Google Scholar 

  2. Cairncross JG, Walker RW, Posner JB: Cerebral herniation complicating cisplatin chemotherapy. Neurology 36 (Suppl 1): 329, 1986

    Google Scholar 

  3. Feun LG, Lee YY, Yung WKA, et al.: Phase II trial of intracarotid BCNU and cisplatin in primary malignant brain tumors. Cancer Drug Deliv 3: 147–156, 1986

    Google Scholar 

  4. Fenn LG, Stewart DJ, Maor M, et al.: A pilot study of cis-diamminedichloroplatinum and radiation therapy in patients with high grade astrocytoma. J Neuro-Oncol 1: 109–114, 1983

    Google Scholar 

  5. Green SB, Byar DP, Walker MD, et al.: Comparison of carmustine, procarbazine, and high-dose methyl-prednisolone as additions to surgery and radiotherapy for the treatment of malignant glioma. Cancer Treat Rep 67: 121–132, 1983

    Google Scholar 

  6. Levin VA, Wilson CB, Davis R, et al.: A phase III comparison of BCNU, hydroxyurea, and radiation therapy to BCNU and radiation therapy for treatment of primary malignant gliomas. J Neurosurg 51: 526–532, 1979

    Google Scholar 

  7. Levin VA, Silver P, Hannigan J, et al.: Superiority of post-radiotherapy adjuvant chemotherapy with CCNU, procarbazine and vincristine (PCV) over BCNU for anaplastic gliomas: NCOG 6G61 final report. Int J Radiation Oncology Biol Phys 18: 321–324, 1990

    Google Scholar 

  8. Levin VA, Sheline GE, Gutin PH: Neoplasms of the central nervous system. In: DeVita VT Jr, Hellman S, Rosenberg SA (eds) Cancer, Principles and Practice of Oncology, 3rd ed. JB Lippincott, Philadelphia, 1989

    Google Scholar 

  9. Nelson JS, Tsukuda Y, Schoenfeld D, et al.: Necrosis as a prognostic criterion in malignant supratentorial gliomas. Cancer 52: 550–554, 1983

    Google Scholar 

  10. Shapiro WR: Therapy of adult malignant brain tumors: What have the clinical trials taught us? Semin Oncol 13: 38–48, 1986

    Google Scholar 

  11. Stanley KE: Prognostic factors for survival in patients with inoperable lung cancer. J Natl Cancer Inst 65: 25–32, 1980

    Google Scholar 

  12. Stewart DJ, Leavens M, Fenn LG, et al.: Human CNS distribution of CDDP and use as a radiosensitizer in malignant brain tumors: Preliminary results. Cancer Res 42: 2474–2479, 1982

    Google Scholar 

  13. Stewart DJ, Lu K, O'Bryan DP, Alexander E, et al.: Phase II study of cisplatin in recurrent astrocytoma in adults: A Southwest Oncology Group study. J Neuro-Oncol 1: 145–148, 1983

    Google Scholar 

  14. Walker MD, Green SB, Byar DP, Alexander E, et al.: Randomized comparison of radiotherapy and nitrosoureas for the treatment of malignant gliomas after surgery. N Eng J Med 303: 1323–1329, 1980

    Google Scholar 

  15. Wolpert DE, Filippes MK: Antitumor activity of cis-diamminedichloroplatinum (II). Cancer Treat Rep 63: 1453–1458, 1979

    Google Scholar 

  16. Walker RW, Allen JC: Treatment of recurrent primary intracranial childhood tumors with cis-diamminedichloroplatinum (Abstract). Ann Neurol 14: 371, 1983

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neuro-Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA

    W. K. Alfred Yung, Todd J. Janus & Lynn G. Feun

  2. Department of Radiotherapy, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA

    Moshe Maor

Authors
  1. W. K. Alfred Yung
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Todd J. Janus
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Moshe Maor
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Lynn G. Feun
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yung, W.K.A., Janus, T.J., Maor, M. et al. Adjuvant chemotherapy with carmustine and cisplatin for patients with malignant gliomas. J Neuro-Oncol 12, 131–135 (1992). https://doi.org/10.1007/BF00172662

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00172662

Key words

Search

Navigation